Researchers from the University of Liverpool have
shown the potential of repurposing an existing and cheap drug into
a long-acting injectable therapy that could be used to treat
COVID-19.
About
Subscribe
If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!
New Fusion
The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.
Subscribe
If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!
New Fusion
The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.